DB
ALLR

Danske Bank’s Allarity Therapeutics ALLR Stock Holding History

Danske Bank’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Hold
1
– – ﹤0.01% 1156
2025
Q4 		$1 Hold
1
– – ﹤0.01% 1545
2025
Q3 		$2 Hold
1
– – ﹤0.01% 1462
2025
Q2 		$1 Hold
1
– – ﹤0.01% 1507
2025
Q1 		$1 Hold
1
– – ﹤0.01% 1353
2024
Q4 		$1 Sell
1
-7
-88% -$9 ﹤0.01% 1391
2024
Q3 		$17 Buy
+8
New +$38 ﹤0.01% 1503

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Danske Bank's ALLR Position: Q1 2026 in Review

Danske Bank held its Allarity Therapeutics (ALLR) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1156.

Danske Bank first reported a position in ALLR in Q3 2024 and has held it in 7 quarters since. The position peaked at $17 in Q3 2024. 14 funds tracked by Wall St. Rank hold ALLR as of Q1 2026.

  • Danske Bank held 1 share of Allarity Therapeutics worth $1 as of Q1 2026.
  • Danske Bank left its Allarity Therapeutics share count unchanged in Q1 2026.
  • Allarity Therapeutics made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1156 holding.
  • Danske Bank first reported a position in Allarity Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Danske Bank's Allarity Therapeutics position peaked at $17 in Q3 2024.
  • 14 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.